Emmanuel Papadakis of Deutsche Bank, Maintained "BioNTech SE" (BNTX) at Hold and Held Target at $180 on, Jun 1st, 2022.
Emmanuel has made no other calls on BNTX in the last 4 months.
There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Emmanuel's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022
- Simon Baker of "Redburn Partners" Upgraded from Strong Sell to Hold on, Tuesday, February 1st, 2022
These are the ratings of the 2 analyists that currently disagree with Emmanuel
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $298 on, Tuesday, April 12th, 2022
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022
